Bridgebio Pharma Inc Earnings

Bridgebio Pharma Inc’s revenue jumped 4999.86% since last year same period to $110.57Mn in the Q2 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated -5.2% fall in its revenue since last 3-months.

Bridgebio Pharma Inc’s net profit fell -147.64% since last year same period to $-181.9Mn in the Q2 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated -8.65% fall in its net profits since last 3-months.

Bridgebio Pharma Inc’s net profit margin jumped 95.14% since last year same period to -164.52% in the Q2 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated -14.61% fall in its net profit margins since last 3-months.

Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.84 - a -12.25% fall from last quarter’s estimates.

Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.84.

Bridgebio Pharma Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Bridgebio Pharma Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.